Gloster Ltd: Intrinsic Value & Share Price Analysis

Last Updated: February 7, 2026, 9:00 pm

All Competitor Stocks of Gloster Ltd

Last Updated: December 26, 2025, 6:16 pm

Below is a detailed analysis of the quarterly data for Gloster Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Sales, as of Sep 2025, the value is 360.11 Cr.. The value appears strong and on an upward trend. It has increased from 305.63 Cr. (Jun 2025) to 360.11 Cr., marking an increase of 54.48 Cr..
• For Expenses, as of Sep 2025, the value is 320.59 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 275.59 Cr. (Jun 2025) to 320.59 Cr., marking an increase of 45.00 Cr..
• For Operating Profit, as of Sep 2025, the value is 39.52 Cr.. The value appears strong and on an upward trend. It has increased from 30.04 Cr. (Jun 2025) to 39.52 Cr., marking an increase of 9.48 Cr..
• For OPM %, as of Sep 2025, the value is 10.97%. The value appears strong and on an upward trend. It has increased from 9.83% (Jun 2025) to 10.97%, marking an increase of 1.14%.
• For Other Income, as of Sep 2025, the value is 2.18 Cr.. The value appears to be declining and may need further review. It has decreased from 5.32 Cr. (Jun 2025) to 2.18 Cr., marking a decrease of 3.14 Cr..
• For Interest, as of Sep 2025, the value is 16.35 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.84 Cr. (Jun 2025) to 16.35 Cr., marking an increase of 0.51 Cr..
• For Depreciation, as of Sep 2025, the value is 14.96 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.25 Cr. (Jun 2025) to 14.96 Cr., marking an increase of 0.71 Cr..
• For Profit before tax, as of Sep 2025, the value is 10.39 Cr.. The value appears strong and on an upward trend. It has increased from 5.27 Cr. (Jun 2025) to 10.39 Cr., marking an increase of 5.12 Cr..
• For Tax %, as of Sep 2025, the value is 26.18%. The value appears to be improving (decreasing) as expected. It has decreased from 43.07% (Jun 2025) to 26.18%, marking a decrease of 16.89%.
• For Net Profit, as of Sep 2025, the value is 7.67 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Jun 2025) to 7.67 Cr., marking an increase of 4.67 Cr..
• For EPS in Rs, as of Sep 2025, the value is 7.01. The value appears strong and on an upward trend. It has increased from 2.74 (Jun 2025) to 7.01, marking an increase of 4.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: December 15, 2025, 3:39 am

Last Updated: September 5, 2025, 3:36 pm

Last Updated: December 4, 2025, 2:58 am

Below is a detailed analysis of the balance sheet data for Gloster Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,071.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,072.00 Cr. (Mar 2025) to 1,071.00 Cr., marking a decrease of 1.00 Cr..
• For Borrowings, as of Sep 2025, the value is 753.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 579.00 Cr. (Mar 2025) to 753.00 Cr., marking an increase of 174.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 371.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 355.00 Cr. (Mar 2025) to 371.00 Cr., marking an increase of 16.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,205.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,018.00 Cr. (Mar 2025) to 2,205.00 Cr., marking an increase of 187.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 1,155.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,115.00 Cr. (Mar 2025) to 1,155.00 Cr., marking an increase of 40.00 Cr..
• For CWIP, as of Sep 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 85.00 Cr. (Mar 2025) to 99.00 Cr., marking an increase of 14.00 Cr..
• For Investments, as of Sep 2025, the value is 116.00 Cr.. The value appears strong and on an upward trend. It has increased from 113.00 Cr. (Mar 2025) to 116.00 Cr., marking an increase of 3.00 Cr..
• For Other Assets, as of Sep 2025, the value is 835.00 Cr.. The value appears strong and on an upward trend. It has increased from 705.00 Cr. (Mar 2025) to 835.00 Cr., marking an increase of 130.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,205.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,018.00 Cr. (Mar 2025) to 2,205.00 Cr., marking an increase of 187.00 Cr..

Notably, the Reserves (1,071.00 Cr.) exceed the Borrowings (753.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for Gloster Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -12.20. This value is below the healthy minimum of 5. It has decreased from 22.25 (Mar 24) to -12.20, marking a decrease of 34.45.
• For Diluted EPS (Rs.), as of Mar 25, the value is -12.20. This value is below the healthy minimum of 5. It has decreased from 22.25 (Mar 24) to -12.20, marking a decrease of 34.45.
• For Cash EPS (Rs.), as of Mar 25, the value is 33.27. This value is within the healthy range. It has decreased from 57.29 (Mar 24) to 33.27, marking a decrease of 24.02.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 990.05. It has decreased from 1,014.47 (Mar 24) to 990.05, marking a decrease of 24.42.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 990.05. It has decreased from 1,014.47 (Mar 24) to 990.05, marking a decrease of 24.42.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 671.45. It has increased from 590.68 (Mar 24) to 671.45, marking an increase of 80.77.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 66.38. This value is within the healthy range. It has decreased from 71.91 (Mar 24) to 66.38, marking a decrease of 5.53.
• For PBIT / Share (Rs.), as of Mar 25, the value is 20.92. This value is within the healthy range. It has decreased from 36.87 (Mar 24) to 20.92, marking a decrease of 15.95.
• For PBT / Share (Rs.), as of Mar 25, the value is -1.11. This value is below the healthy minimum of 0. It has decreased from 34.55 (Mar 24) to -1.11, marking a decrease of 35.66.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -12.20. This value is below the healthy minimum of 2. It has decreased from 22.25 (Mar 24) to -12.20, marking a decrease of 34.45.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -12.20. This value is below the healthy minimum of 2. It has decreased from 22.25 (Mar 24) to -12.20, marking a decrease of 34.45.
• For PBDIT Margin (%), as of Mar 25, the value is 9.88. This value is below the healthy minimum of 10. It has decreased from 12.17 (Mar 24) to 9.88, marking a decrease of 2.29.
• For PBIT Margin (%), as of Mar 25, the value is 3.11. This value is below the healthy minimum of 10. It has decreased from 6.24 (Mar 24) to 3.11, marking a decrease of 3.13.
• For PBT Margin (%), as of Mar 25, the value is -0.16. This value is below the healthy minimum of 10. It has decreased from 5.84 (Mar 24) to -0.16, marking a decrease of 6.00.
• For Net Profit Margin (%), as of Mar 25, the value is -1.81. This value is below the healthy minimum of 5. It has decreased from 3.76 (Mar 24) to -1.81, marking a decrease of 5.57.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -1.81. This value is below the healthy minimum of 8. It has decreased from 3.76 (Mar 24) to -1.81, marking a decrease of 5.57.
• For Return on Networth / Equity (%), as of Mar 25, the value is -1.23. This value is below the healthy minimum of 15. It has decreased from 2.19 (Mar 24) to -1.23, marking a decrease of 3.42.
• For Return on Capital Employeed (%), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 10. It has decreased from 3.04 (Mar 24) to 1.44, marking a decrease of 1.60.
• For Return On Assets (%), as of Mar 25, the value is -0.66. This value is below the healthy minimum of 5. It has decreased from 1.65 (Mar 24) to -0.66, marking a decrease of 2.31.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has increased from 0.10 (Mar 24) to 0.32, marking an increase of 0.22.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.52. This value is within the healthy range. It has increased from 0.16 (Mar 24) to 0.52, marking an increase of 0.36.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. It has decreased from 0.46 (Mar 24) to 0.42, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 1.54. This value is within the healthy range. It has decreased from 2.04 (Mar 24) to 1.54, marking a decrease of 0.50.
• For Quick Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.83, marking a decrease of 0.15.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.18. This value is below the healthy minimum of 4. It has decreased from 4.28 (Mar 24) to 3.18, marking a decrease of 1.10.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -163.98. This value is below the healthy minimum of 20. It has decreased from 89.87 (Mar 24) to -163.98, marking a decrease of 253.85.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 60.11. This value exceeds the healthy maximum of 50. It has increased from 34.90 (Mar 24) to 60.11, marking an increase of 25.21.
• For Earning Retention Ratio (%), as of Mar 25, the value is 263.98. This value exceeds the healthy maximum of 70. It has increased from 10.13 (Mar 24) to 263.98, marking an increase of 253.85.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 39.89. This value is below the healthy minimum of 40. It has decreased from 65.10 (Mar 24) to 39.89, marking a decrease of 25.21.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.01. This value is within the healthy range. It has decreased from 31.05 (Mar 24) to 3.01, marking a decrease of 28.04.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 3. It has decreased from 10.61 (Mar 24) to 0.44, marking a decrease of 10.17.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,165.92. It has increased from 1,046.99 (Mar 24) to 1,165.92, marking an increase of 118.93.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has decreased from 1.62 (Mar 24) to 1.59, marking a decrease of 0.03.
• For EV / EBITDA (X), as of Mar 25, the value is 16.05. This value exceeds the healthy maximum of 15. It has increased from 13.30 (Mar 24) to 16.05, marking an increase of 2.75.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 1.39 (Mar 24) to 0.84, marking a decrease of 0.55.
• For Retention Ratios (%), as of Mar 25, the value is 263.98. This value exceeds the healthy maximum of 70. It has increased from 10.12 (Mar 24) to 263.98, marking an increase of 253.86.
• For Price / BV (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.57, marking a decrease of 0.23.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 1.39 (Mar 24) to 0.84, marking a decrease of 0.55.
• For EarningsYield, as of Mar 25, the value is -0.02. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to -0.02, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

About the Company - Qualitative Analysis